







Wembrace Biopharma is India’s 1st Comprehensive Oncology Pharma Company, With over 35+ years of experience in handling advanced oncology products, nutraceuticals and onco-cosmeceuticals . We aggressively works toward innovation and accessibility to ensure quality of life of patients.
Wembrace Biopharma: Global Cancer Pharmaceutical Companies Driving Breakthrough Therapies
Wembrace Biopharma, headquartered in Delhi, India, is among the most trusted oncology pharma companies, dedicated to improving global cancer care. With over 30 years of experience, we specialize in developing advanced oncology products and nutraceutical solutions that enhance the quality of life for patients worldwide. Our mission is rooted in compassion, innovation, and accessibility, ensuring every therapy we deliver brings real impact.
As one of the leading cancer medicine companies, Wembrace focuses on affordability without compromising on quality. Our portfolio includes more than 50 high-quality formulations that reflect our commitment to making effective treatment available to all. Patients and healthcare providers alike trust us to provide safe, reliable, and breakthrough therapies.
Positioned globally among innovative cancer pharmaceutical companies, Wembrace is driven by research excellence and a passion for better outcomes. We uphold values of integrity and scientific rigor, ensuring each solution we create contributes meaningfully to healthcare advancements.
Beyond research, we are recognized as one of the most dependable oncology drug companies, uniting expertise and empathy. At Wembrace, our vision is to create a future where compassionate care, innovative medicines, and accessibility define the fight against cancer—delivering hope and healing worldwide.
Oncology Products
Wembrace Biopharma offers a comprehensive range of pharmaceutical and nutraceutical specialty products, driven by ongoing research and innovation in Oncology. As one of the emerging Oncology drug companies, we provide solid and liquid orals, dry syrups, suspensions, capsules (both hard and soft shells), chewable and dissolvable tablets, as well as lyophilised lipid suspensions and ready-to-use liquid injectable forms. Our diverse Oncology products are developed to ensure maximum effectiveness and preserved shelf life, keeping patient well-being at the core.
Among leading Oncology pharma companies, Wembrace Biopharma is dedicated to building advanced therapies that bring real clinical value. We focus on innovation, safety, and accessibility, while embracing the vision to “Smile with Miles” – a commitment to spreading hope, trust, and better health outcomes for every patient.
Latest Introduction
Touching Almost All Aspects of Healthcare Milestones





50% Cancer Patients Receive
Radiation Therapy
50% Cancer Patients Receive
Radiation Therapy
50% Cancer Patients Receive
Radiation Therapy
Around 95% of them develop radiation induced Dermatitis (RID).
Around 95% of them develop radiation induced Dermatitis (RID).
Around 95% of them develop radiation induced Dermatitis (RID).









Keratolytic activity
Keratolytic activity
Keratolytic activity
Safe, Acts as an Ideal Humactant
@20% concentration
Safe, Acts as an Ideal Humactant
@20% concentration
Safe, Acts as an Ideal Humactant
@20% concentration
100% Natural & Plant Derived Binds to Skin like Magnet
100% Natural & Plant Derived Binds to Skin like Magnet
100% Natural & Plant Derived Binds to Skin like Magnet
Unique skin Identical Carbohydrate comples gives Potent Hydration
Unique skin Identical Carbohydrate comples gives Potent Hydration
Unique skin Identical Carbohydrate comples gives Potent Hydration
Products Portfolio
Most Popular Stories

Cancer today: a compact scientific brief for clinicians and informed readers
Cancer’s global footprint keeps growing; ageing populations and changing exposures (tobacco, obesity, pollution) are driving a projected rise in new cases and deaths over the

Lung Cancer Unmasked: Classification & Risk factors
Lung cancer is one of the most common malignant cancers in most countries and is the leading cause of death among cancer diseases worldwide.1 The

Pancreatic Cancer – A Deep Dive into Facts, India’s Landscape & Emerging Therapies
Pancreatic cancer remains one of the most formidable malignancies: relatively rare compared to others, yet disproportionately deadly. In this blog, we’ll explore key facts about